If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...

Most Parkinson's symptoms stem from the loss or dysfunction of dopamine-producing neurons in a brain region involved in fine ...

Parkinson’s disease (PD) is the fastest-growing neurological disorder globally, affecting nearly one million people in the ...

For neurologist and movement disorder specialist Dr. Jill Giordano Farmer, the fight against Parkinson’s isn’t just ...

An estimated 1.1 million Americans are living with Parkinson’s disease (PD), making it the second most common neurodegenerative disease after Alzheimer’s. “Parkinson’s is a disease in which neurons ...

Some doctors say the chemicals all around us may be increasing our risk of Parkinson’s disease, the fastest-growing neurodegenerative disorder in the world.

What happens in the brain when a person experiences the characteristic movement symptoms of Parkinson's disease? Researchers ...

The world's largest clinical trial for Parkinson’s disease has commenced, aiming to identify treatments that can slow or halt ...

Parkinson's disease (PD) is a widespread neurological ailment that is becoming more prevalent as the world's population ages. It is estimated that approximately 10 million people worldwide are ...

For decades, medical understanding of Parkinson’s disease focused exclusively on the brain, specifically the death of dopamine-producing neurons that control movement. This narrow view shaped ...

Parkinson's disease is fundamentally a breakdown in the functioning of a part of the brain called the basal ganglia, robbing ...

Parkinson’s disease is a neurodegenerative disorder that causes a gradual loss of brain nerve cells, which produce a chemical messenger called dopamine. Dopamine relays signals throughout the brain ...